SINGULAIR 5 MG TABLET CHEW

montelukast sodium
$9.2741per EA
High Outlier

Strength

5 mg/1

Manufacturer

Organon LLC

NDC

78206017301

Classification

Brand

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

MONTELUKAST SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA020830

On Market Since

6/1/2021

Pharmacological Classes

Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+5.0%

1Y

+5.0%

3Y

N/A

5Y

N/A

All

+9.8%

Related Drugs

Same classification

No related drugs found.